Shanghai Serum Bio-Technology Co Ltd banner
S

Shanghai Serum Bio-Technology Co Ltd
SSE:688163

Watchlist Manager
Shanghai Serum Bio-Technology Co Ltd
SSE:688163
Watchlist
Price: 26.18 CNY 4.55%
Market Cap: ¥2.8B

Relative Value

The Relative Value of one Shanghai Serum Bio-Technology Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 26.18 CNY, Shanghai Serum Bio-Technology Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Shanghai Serum Bio-Technology Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Shanghai Serum Bio-Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai Serum Bio-Technology Co Ltd
SSE:688163
2.8B CNY 14.3 62.9 61.5 61.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 643 258.8 -159 901.4 -194 171.3 -191 955.6
US
Abbvie Inc
NYSE:ABBV
386.2B USD 6.5 164.5 16 22.7
US
Amgen Inc
NASDAQ:AMGN
197.1B USD 5.4 25.6 14.7 14.7
US
Gilead Sciences Inc
NASDAQ:GILD
185.2B USD 6.4 22.8 15.5 15.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.4B USD 9.9 31.7 23.2 24.3
US
Epizyme Inc
F:EPE
94.1B EUR 2 094 -534.3 -581.8 -566.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.9B USD 5.6 18 15.2 17.4
AU
CSL Ltd
ASX:CSL
87.1B AUD 3.9 20.2 13.5 16.8
NL
argenx SE
XBRU:ARGX
43.9B EUR 14.5 34 58.1 59.7
US
Seagen Inc
F:SGT
39.3B EUR 20.2 -61.8 -66.7 -60.2
P/S Multiple
Revenue Growth P/S to Growth
CN
S
Shanghai Serum Bio-Technology Co Ltd
SSE:688163
Average P/S: 3 058 676.3
14.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 643 258.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.5
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
5.4
2%
2.7
US
Gilead Sciences Inc
NASDAQ:GILD
6.4
4%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
10%
1
US
E
Epizyme Inc
F:EPE
2 094
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
8%
0.7
AU
CSL Ltd
ASX:CSL
3.9
5%
0.8
NL
argenx SE
XBRU:ARGX
14.5
49%
0.3
US
S
Seagen Inc
F:SGT
20.2
30%
0.7
P/E Multiple
Earnings Growth PEG
CN
S
Shanghai Serum Bio-Technology Co Ltd
SSE:688163
Average P/E: 47.4
62.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 901.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
164.5
89%
1.8
US
Amgen Inc
NASDAQ:AMGN
25.6
18%
1.4
US
Gilead Sciences Inc
NASDAQ:GILD
22.8
191%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.7
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
9%
2
AU
CSL Ltd
ASX:CSL
20.2
11%
1.8
NL
argenx SE
XBRU:ARGX
34
42%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
S
Shanghai Serum Bio-Technology Co Ltd
SSE:688163
Average EV/EBITDA: 27.2
61.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 171.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
14.7
10%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
15.5
7%
2.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.2
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.2
24%
0.6
AU
CSL Ltd
ASX:CSL
13.5
8%
1.7
NL
argenx SE
XBRU:ARGX
58.1
810%
0.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
S
Shanghai Serum Bio-Technology Co Ltd
SSE:688163
Average EV/EBIT: 29.1
61.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 955.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
14.7
2%
7.3
US
Gilead Sciences Inc
NASDAQ:GILD
15.5
13%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.3
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.4
23%
0.8
AU
CSL Ltd
ASX:CSL
16.8
11%
1.5
NL
argenx SE
XBRU:ARGX
59.7
N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.2 N/A N/A